Disease Overview：Retinal Artery Occlusion（RAO）
Retinal artery occlusion (RAO) is a sight-threatening ophthalmic emergency characterized by abrupt, painless vision loss due to interruption of blood flow in the central or branch retinal artery. It most commonly results from embolic material—often originating from carotid atherosclerosis or cardiac sources—or less frequently from vasculitis, hypercoagulable states, or giant cell arteritis. Central retinal artery occlusion (CRAO) typically causes profound monocular visual impairment, while branch retinal artery occlusion (BRAO) presents with sectoral visual field defects. Time is critical: irreversible retinal ischemia begins within 90–240 minutes of occlusion, making urgent intervention essential. Diagnostic evaluation includes fundoscopy (revealing pale retina with cherry-red macula in CRAO), optical coherence tomography (OCT), fluorescein angiography, and systemic workup for cardiovascular risk factors and embolic sources. Treatment options remain limited but evolving—emergent measures may include ocular massage, anterior chamber paracentesis, intraocular pressure reduction, and hyperbaric oxygen therapy; newer approaches under investigation include intravenous thrombolysis and intra-arterial fibrinolysis in select centers.
China offers distinct advantages for RAO management: leading ophthalmology centers—such as Beijing Tongren Hospital and Shanghai Eye & ENT Hospital—combine deep subspecialty expertise in retinal vascular disorders with state-of-the-art imaging (e.g., swept-source OCT angiography) and advanced interventional capabilities. Clinical outcomes reflect this strength: published case series report improved visual acuity recovery rates in patients treated within 3 hours using multimodal protocols, including selective intra-arterial urokinase delivery under digital subtraction angiography guidance. Compared to Western counterparts, treatment costs in China are typically 40–60% lower without compromising diagnostic rigor or procedural standards. As a dedicated medical tourism agency, we facilitate seamless access for international patients—handling hospital referrals, coordinating urgent appointments, verifying physician credentials, providing transparent all-inclusive pricing, and offering end-to-end support from visa assistance to post-treatment follow-up coordination.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Retinal Arterial Occlusion
Non-Surgical / Conservative Management
*Target criteria*: Acute presentation (<24 hours), no contraindications to vasodilation or anticoagulation, absence of active bleeding or severe systemic comorbidities (e.g., uncontrolled hypertension, recent stroke).
- •Emergency ocular massage + anterior chamber paracentesis
- Fee: $180–$220 (includes physician fee, sterile procedure kit, topical anesthetic)
- •Intravenous acetazolamide + sublingual isosorbide dinitrate
- Medication + infusion + nursing care: $260–$310
- •Oral antiplatelet therapy (aspirin 100 mg/day) + statin optimization
- •Comprehensive diagnostic workup (mandatory)
Surgical / Procedural Intervention
*Eligibility*: Confirmed central retinal artery occlusion (CRAO) within 8 hours; documented embolic source (e.g., carotid plaque ≥70%, atrial fibrillation); no contraindications to thrombolysis.
- •Intra-arterial thrombolysis (via femoral catheterization)
- Procedure fee (including catheter, urokinase/tPA, angiography): $1,850–$2,300 - Preoperative: CT angiography (carotid + circle of Willis), neurology consult, INR <1.5: $290–$360
- •Carotid endarterectomy (if symptomatic stenosis ≥70%)
- Surgery + anesthesia + 3-day ICU monitoring: $4,200–$5,100 - Preoperative: Duplex ultrasound + cardiac stress test + pulmonary function test: $210–$270
Special / Complex Condition Management
- •Bilateral simultaneous occlusion or recurrent CRAO: Requires urgent rheumatology & hematology referral for vasculitis/thrombophilia workup (ANCA, lupus anticoagulant, protein C/S, factor V Leiden): $480–$620
- •CRAO with concurrent optic nerve infarction (anterior ischemic optic neuropathy): High-dose IV methylprednisolone (500 mg × 3 days) + plasma exchange (3 sessions): $1,350–$1,720
Quick Selection Guide
- •<50 years, no vascular risk factors, sudden monocular vision loss: Prioritize emergency ocular massage + paracentesis ($200) + full thrombophilia panel ($620) — *optimal for identifying rare inherited causes*.
- •65–75 years, known AFib or carotid stenosis, onset <6 hrs: Proceed directly to intra-arterial thrombolysis ($2,100) + pre-op angiography ($330) — *highest evidence for visual recovery if timely*.
- •>80 years or severe comorbidities (NYHA III–IV HF, CKD stage 4): Conservative management only ($310 total) — *surgical risk outweighs benefit; focus on secondary prevention*.
- •Recurrent events despite aspirin/statin: Add clopidogrel + rivaroxaban (off-label) + carotid imaging ($540) — *cost-effective for preventing further occlusion*.
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Retinal Artery Occlusion Medical Vacation Packages
Curated transparent all-inclusive packages combining Retinal Artery Occlusion treatment with China top medical destinations:
